A decrease in circulating levels of immunoreactive insulin-like growth factor binding protein-1 (IGFBP-1) after endometrial ablation using a gynecologic resectoscope.
To determine how endometrium alone would contribute to maintaining the circulating levels of Insulin-like growth factor binding protein-1 in vivo, serum immunoreactive IGFBP-1 levels were measured in 19 patients undergoing endometrial ablation using gynecologic resectoscopy. After endometrial ablation there was a significant decrease in the mean levels of circulating IGFBP-1, which was not correlated with the menstrual cycle. This result indicates that the endometrium is one of the sources of the circulating IGFBP-1.
Park
K H
KH
Department of Obstetrics and Gynecology, Yonsei University College of Medicine, Seoul, Korea. jny6693@yumc.yonsei.ac.kr
Lee
B S
BS
Kim
J Y
JY
Cho
D J
DJ
Song
C H
CH
Lee
S J
SJ
D000328:Adult; D004717:Endometrium / Q000601:surgery*; D019723:Endoscopes; D005260:Female; D006801:Humans; D018970:Insulin-Like Growth Factor Binding Protein 1 / Q000097:blood*; D008598:Menstruation; D008875:Middle Aged
D018970:Insulin-Like Growth Factor Binding Protein 1